Overcoming therapy resistance in EGFR-mutant lung cancer

被引：388

作者：

Passaro, Antonio ^{[1
]}

Janne, Pasi A. ^{[2
,3
]}

Mok, Tony ^{[4
]}

Peters, Solange ^{[5
]}

机构：

[1] IRCCS, European Inst Oncol, Div Thorac Oncol, Milan, Italy

[2] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA

[3] Harvard Med Sch, Boston, MA 02115 USA

[4] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R China

[5] Ctr Hosp Univ Vaudois CHUV, Dept Oncol, Lausanne, Switzerland

来源：

NATURE CANCER | 2021年 / 2卷 / 04期

关键词：

GROWTH-FACTOR RECEPTOR; CIRCULATING TUMOR DNA; CISPLATIN PLUS GEMCITABINE; PHASE-III TRIAL; CELL-FREE DNA; OPEN-LABEL; BRAIN METASTASES; DRUG-RESISTANCE; T790M MUTATION; 1ST-LINE TREATMENT;

D O I：

10.1038/s43018-021-00195-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tyrosine kinase inhibitors (TKIs) have dramatically changed the clinical prospects of patients with non-small cell lung cancer harboring epidermal growth factor receptor (EGFR)-activating mutations. Despite prolonged disease control and high tumor response rates, all patients eventually progress on EGFR TKI treatment. Here, we review the mechanisms of acquired EGFR TKI resistance, the methods for monitoring its appearance, as well as current and future efforts to define treatment strategies to overcome resistance. Passaro and colleagues discuss recent advances in treating EGFR-mutant lung cancer, including methods for detecting disease and tracking therapy response, developments in understanding of resistance mechanisms and ongoing clinical trials to circumvent therapeutic resistance to EGFR targeting.

引用

页码：377 / 391

页数：15

共 189 条

[11] Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial [J].

Bennouna, Jaafar ;

Girard, Nicolas ;

Audigier-Valette, Clarisse ;

le Thuaut, Aurelie ;

Gervais, Radj ;

Masson, Philippe ;

Marcq, Marie ;

Molinier, Olivier ;

Cortot, Alexis ;

Debieuvre, Didier ;

Cadranel, Jacques ;

Lena, Herve ;

Moro-Sibilot, Denis ;

Chouaid, Christos ;

Mennecier, Bertrand ;

Urban, Thierry ;

Sagan, Christine ;

Perrier, Ludivine ;

Barlesi, Fabrice ;

Denis, Marc G. .

CLINICAL LUNG CANCER, 2020, 21 (01) :E10-E14

[12] NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer [J].

Blakely, Collin M. ;

Pazarentzos, Evangelos ;

Olivas, Victor ;

Asthana, Saurabh ;

Yan, Jenny Jiacheng ;

Tan, Irena ;

Hrustanovic, Gorjan ;

Chan, Elton ;

Lin, Luping ;

Neel, Dana S. ;

Newton, William ;

Bobb, Kathryn L. ;

Fouts, Timothy R. ;

Meshulam, Jeffrey ;

Gubens, Matthew A. ;

Jablons, David M. ;

Johnson, Jeffrey R. ;

Bandyopadhyay, Sourav ;

Krogan, Nevan J. ;

Bivona, Trever G. .

CELL REPORTS, 2015, 11 (01) :98-110

[13] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[14] On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation [J].

Brown, Benjamin P. ;

Zhang, Yun-Kai ;

Westover, David ;

Yan, Yingjun ;

Qiao, Huan ;

Huang, Vincent ;

Du, Zhenfang ;

Smith, Jarrod A. ;

Ross, Jeffrey S. ;

Miller, Vincent A. ;

Ali, Siraj ;

Bazhenova, Lyudmila ;

Schrock, Alexa B. ;

Meiler, Jens ;

Lovly, Christine M. .

CLINICAL CANCER RESEARCH, 2019, 25 (11) :3341-3351

[15] Semaphorin receptors meet receptor tyrosine kinases on the way of tumor progression [J].

Cagnoni, G. ;

Tamagnone, L. .

ONCOGENE, 2014, 33 (40) :4795-4802

[16] Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC) [J].

Camidge, D. Ross ;

Ou, Sai-Hong Ignatius ;

Shapiro, Geoffrey ;

Otterson, Gregory Alan ;

Villaruz, Liza Cosca ;

Villalona-Calero, Miguel Angel ;

Iafrate, A. John ;

Varella-Garcia, Marileila ;

Dacic, Sanja ;

Cardarella, Stephanie ;

Zhao, Weiqiang ;

Tye, Lesley ;

Stephenson, Patricia ;

Wilner, Keith D. ;

James, Leonard Philip ;

Socinski, Mark A. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[17] Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients [J].

Cappuzzo, Federico ;

Marchetti, Antonio ;

Skokan, Margaret ;

Rossi, Elisa ;

Gajapathy, Sujatha ;

Felicioni, Lara ;

del Grammastro, Maela ;

Sciarrotta, Maria Grazia ;

Buttitta, Fiamma ;

Incarbone, Matteo ;

Toschi, Luca ;

Finocchiaro, Giovanna ;

Destro, Annarita ;

Terracciano, Luigi ;

Roncalli, Massimo ;

Alloisio, Marco ;

Santoro, Armando ;

Varella-Garcia, Marileila .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) :1667-1674

[18] MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC) [J].

Casadevall, David ;

Gimeno, Javier ;

Clave, Sergi ;

Taus, Alvaro ;

Pijuan, Lara ;

Arumi, Miriam ;

Lorenzo, Marta ;

Menendez, Silvia ;

Canadas, Israel ;

Albanell, Joan ;

Serrano, Sergio ;

Espinet, Blanca ;

Salido, Marta ;

Arriola, Edurne .

ONCOTARGET, 2015, 6 (18) :16215-16226

[19] Circulating tumor DNA and liquid biopsy in oncology [J].

Cescon, David W. ;

Bratman, Scott, V ;

Chan, Steven M. ;

Siu, Lillian L. .

NATURE CANCER, 2020, 1 (03) :276-290

[20] Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients [J].

Chabon, Jacob J. ;

Simmons, Andrew D. ;

Lovejoy, Alexander F. ;

Esfahani, Mohammad S. ;

Newman, Aaron M. ;

Haringsma, Henry J. ;

Kurtz, David M. ;

Stehr, Henning ;

Scherer, Florian ;

Karlovich, Chris A. ;

Harding, Thomas C. ;

Durkin, Kathleen A. ;

Otterson, Gregory A. ;

Purcell, W. Thomas ;

Camidge, D. Ross ;

Goldman, Jonathan W. ;

Sequist, Lecia V. ;

Piotrowska, Zofia ;

Wakelee, Heather A. ;

Neal, Joel W. ;

Alizadeh, Ash A. ;

Diehn, Maximilian .

NATURE COMMUNICATIONS, 2016, 7

← 1 2 3 4 5 6 7 8 9 10 →